文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

联合放射组学模型预测创伤性脑损伤脑挫裂伤血肿进展与临床结局

Combined Radiomics Model for Prediction of Hematoma Progression and Clinical Outcome of Cerebral Contusions in Traumatic Brain Injury.
PubMed 文献 · Neurocrit Care · 2021-08-04
一句话结论在创伤性脑损伤脑挫裂伤患者中,融合放射组学特征与临床因素的列线图可无创预测血肿进展和GOS结局,AUC分别提升至0.899和0.844。

血肿进展相关临床因素包括INR、PT和纤维蛋白原;GOS相关因素包括治疗策略、年龄、GCS评分和血小板。融合放射组学特征后,血肿进展预测AUC从0.832升至0.899,GOS预测AUC从0.794升至0.844。提示放射组学联合临床特征可作为无创工具辅助预后判断。

要点

  • 同一队列中,融合放射组学特征后GOS预测AUC从0.794提高至0.844。
  • 血肿进展相关临床因素包括INR、PT和纤维蛋白原,GOS相关因素包括治疗策略、年龄、GCS评分和血小板。
  • 共构建4个列线图,分别基于临床因素单独或融合放射组学特征预测血肿进展和GOS。

适用人群与场景

  • 原文未提及排除人群、急诊或ICU具体场景及病情阶段。

诊断标准与关键阈值

  • 血肿进展相关临床因素包括INR、PT和纤维蛋白原;GOS相关因素包括治疗策略、年龄、GCS评分和血小板。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 主要终点结果:融合放射组学特征后,血肿进展预测AUC从0.832升至0.899;GOS预测AUC从0.794升至0.844。
  • 关键次要终点:血肿进展相关临床因素为INR、PT、纤维蛋白原;GOS相关因素为治疗策略、年龄、GCS评分、血小板。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 证据等级或推荐强度:原文未提及。

对床旁实践的改变

  • 该模型为无创预测工具,可能辅助识别脑挫裂伤后血肿进展和GOS结局高风险患者,但需前瞻性验证后才能用于床旁决策。
  • 适用人群为经病理诊断的创伤性脑损伤脑挫裂伤患者,不适用于其他人群。
  • 常见陷阱:不能将回顾性研究的AUC值直接作为决策阈值,不能将研究中的临床因素关联误读为因果或治疗推荐。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Traumatic brain injury is a common and devastating injury that is the leading cause of neurological disability and death worldwide. Patients with cerebral lobe contusion received conservative treatment because of their mild manifestations, but delayed intracranial hematoma may increase and even become life-threatening. We explored the noninvasive method to predict the prognosis of progression and Glasgow Outcome Scale (GOS) by using a quantitative radiomics approach and statistical analysis.

METHODS: Eighty-eight patients who were pathologically diagnosed were retrospectively studied. The radiomics method developed in this work included image segmentation, feature extraction, and feature selection. The nomograms were established based on statistical analysis and a radiomics method. We conducted a comparative study of hematoma progression and GOS between the clinical factor alone and fusion radiomics features.

RESULTS: Nineteen clinical factors, 513 radiomics features, and 116 locational features were considered. Among clinical factors, international normalized ratio, prothrombin time, and fibrinogen were enrolled for hematoma progression. As for GOS, treatment strategy, age, Glasgow Coma Scale score, and blood platelet were associated factors. Eight features for GOS and five features for hematoma progression were filtered by using sparse representation and locality preserving projection-combined method. Four nomograms were constructed. After fusion radiomics features, area under the curve of hematoma progression prediction increased from 0.832 to 0.899, whereas GOS prediction went from 0.794 to 0.844.

CONCLUSIONS: A radiomic-based model that merges radiomics and clinical features is a noninvasive approach to predict hematoma progression and clinical outcomes of cerebral contusions in traumatic brain injury.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Zhang L, Zhuang Q, Wu G, et al. Combined Radiomics Model for Prediction of Hematoma Progression and Clinical Outcome of Cerebral Contusions in Traumatic Brain Injury. Neurocrit Care. 2021. PMID: 34350554. doi:10.1007/s12028-021-01320-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。